Autoimmune hemolytic anemia in a patient with acute myelogenous leukemia treated with low-dose interleukin-2 after autologous bone marrow transplantation

Blood. 1995 Jul 15;86(2):837-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Anemia, Hemolytic / chemically induced*
  • Anemia, Hemolytic, Autoimmune / chemically induced*
  • Bone Marrow Transplantation*
  • Combined Modality Therapy
  • Female
  • Humans
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / adverse effects*
  • Leukemia, Myeloid / therapy
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / metabolism
  • Middle Aged
  • Receptors, Interleukin-2 / drug effects
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Remission Induction

Substances

  • Interleukin-2
  • Receptors, Interleukin-2
  • Recombinant Proteins